Normally, cell proliferation and death are cautiously balanced in higher eukaryotes, but probably one of the most important regulatory mechanisms, apoptosis, is definitely upset in many malignancies, including hepatocellular-derived ones. both LMP and death induced by TNF/CHX. Taken GW 5074 collectively, our results demonstrate that lysosomal build up of ceramide is not detrimental per se, whereas its degradation product sphingosine, which has the capacity to induce LMP, appears responsible for the observed apoptotic-like death. Keywords: ceramide, hepatocellular carcinoma, lysosomes, sphingolipids, tumor necrosis element- A tightly controlled balance between cellular proliferation and death is the basis for cells homeostasis in multicellular organisms. Dysregulation of this poise results in irregular production or loss of cells, accounting for common diseases such as neurodegenerative disorders and malignancies. Malignant transformation would not occur in the presence of undamaged cell suicide mechanisms. However, due to mutations in oncogenes and tumor suppressor genes, malignancies are often characterized by improved resistance to apoptogenic providers rather than by enhanced proliferation (examined in Ref. 1). Liver malignancies are not exceptions (2), and hence, resistance to programmed cell death (PCD) helps their substantial lack of level of sensitivity to irradiation and anticancer medicines (3). Consequently, many efforts have been devoted to develop new strategies for the treatment of malignant hepatomas that cannot be surgically eliminated. The cytotoxic cytokine tumor necrosis element- (TNF), a member of a family of ligands for a number of death receptors that also includes FASL and TRAIL, is of interest for its partial selectivity for malignant cells (4, 5). Ligation of death receptors results in a cascade of events CACNA1D that is eventually followed by PCD (6). For some cytokines, e.g., FASL, the molecular events spanning from receptor engagement to cell death have been detailed, whereas for TNF, the precise signaling still remains elusive. TNF effects differ depending on variations in rate of metabolism and content of pro- and antiapoptotic proteins among cell types (7, 8). Besides classical caspase-dependent apoptosis and other forms of death, TNF-induced PCD can take place through caspase-independent, apoptosis-like processes that exploit option mechanisms including lysosomal membrane permeabilization GW 5074 (LMP). Although already hinted at long ago (9), the involvement of LMP in apoptosis was long overlooked, but today it is generally acknowledged (10C18). TNF-induced cytotoxicity was also found to involve formation of ceramide, achieved by involvement of acid or neutral sphingomyelinases (aSMase, nSMase) or activation of the de novo pathway, yet the role of these enzymes is definitely debated (19, 20). Recently, the role played by ceramide in TNF cytotoxicity was reevaluated because during TNF-induced PCD, sphingolipids other than ceramide, such as sphingosine, will also be affected (21C25). As the second option is a break up product of ceramide, it is often not easy to discriminate between the effects GW 5074 of these two sphingolipids. Inside a earlier article, we explained that, in rat hepatoma-derived HTC cells, TNF in association with cycloheximide (CHX) induces an apoptosis-like death that involves the lysosomal compartment (26). As this death was prevented by a putative aSMase inhibitor, desipramine (Dpm), we next investigated whether a ceramide-related mechanism is involved in it (23). The results indicated that ceramide-induced death mechanistically differs from that induced by TNF/CHX, therefore ruling out a direct part of ceramide in the second option. However, the results from these studies (23, 26) did not satisfactorily answer the question as to whether TNF treatment alters cellular levels of ceramide or additional sphingolipids that may be involved in TNF-induced death. This problem is definitely resolved in the present work, showing that ligation of the TNF receptor causes the generation of ceramide and sphingosine, and that the lysosomotropic and detergent properties of the second option induce LMP, therefore mediating HTC cell death. MATERIALS AND METHODS Reagents Unless normally indicated, chemicals were from Sigma-Aldrich (Milan, Italy). Human being recombinant TNF- was from R & D Systems (Minneapolis, MN). CHX and Dpm were dissolved in sterile water, C2-ceramide (C2-cer) and sphingosine (Sph) in DMSO. Vehicles alone were added in control ethnicities. The anti-neutral sphingomyelinase 2 (nSMase; H-195, sc-67305) and anti-cathepsin B antibodies (CB; C-19, sc-6490) were from Santa Cruz Biotechnology (Heidelberg, Germany); the anti-acid sphingomyelinase (aSMase; AP12227b) from Abgent (Oxfordshire, UK); the anti-acid ceramidase (aCDase; 612302, clone 23) from BD Biosciences (Buccinasco, Milan, Italy); and the anti–actin (clone AC-15) from Sigma-Aldrich (Milan, Italy). Cell ethnicities The rat hepatoma cell collection HTC was regularly grown inside a 1:1 mixture of DMEM/Ham’s F12 medium (Sigma-Aldrich), comprising 10% FBS (Gibco, Milan, Italy), 2 mM glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin GW 5074 in humidified air flow with added 5% CO2. The human being hepatoma cell lines Hep G2 and Huh7 were cultivated in DMEM (Sigma-Aldrich), the SK-HEP-1 cells in DMEM/Ham’s F12 medium..